Works by Skyler, Jay S.

Results: 169
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    HLA Class II (DR , DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07).

    Published in:
    Diabetes Care, 2024, v. 47, n. 5, p. 826, doi. 10.2337/dc23-1947
    By:
    • Zhao, Lue Ping;
    • Papadopoulos, George K.;
    • Skyler, Jay S.;
    • Pugliese, Alberto;
    • Parikh, Hemang M.;
    • Kwok, William W.;
    • Lybrand, Terry P.;
    • Bondinas, George P.;
    • Moustakas, Antonis K.;
    • Wang, Ruihan;
    • Pyo, Chul-Woo;
    • Nelson, Wyatt C.;
    • Geraghty, Daniel E.;
    • Lernmark, Åke
    Publication type:
    Article
    11
    12

    Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial.

    Published in:
    Diabetes Care, 2023, v. 46, n. 5, p. 1005, doi. 10.2337/dc22-2200
    By:
    • Russell, William E.;
    • Bundy, Brian N.;
    • Anderson, Mark S.;
    • Cooney, Laura A.;
    • Gitelman, Stephen E.;
    • Goland, Robin S.;
    • Gottlieb, Peter A.;
    • Greenbaum, Carla J.;
    • Haller, Michael J.;
    • Krischer, Jeffrey P.;
    • Libman, Ingrid M.;
    • Linsley, Peter S.;
    • Long, S. Alice;
    • Lord, Sandra M.;
    • Moore, Daniel J.;
    • Moore, Wayne V.;
    • Moran, Antoinette M.;
    • Muir, Andrew B.;
    • Raskin, Philip;
    • Skyler, Jay S.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA<sub>1c</sub> in New-Onset Type 1 Diabetes.

    Published in:
    2018
    By:
    • Haller, Michael J.;
    • Schatz, Desmond A.;
    • Skyler, Jay S.;
    • Krischer, Jeffrey P.;
    • Bundy, Brian N.;
    • Miller, Jessica L.;
    • Atkinson, Mark A.;
    • Becker, Dorothy J.;
    • Baidal, David;
    • DiMeglio, Linda A.;
    • Gitelman, Stephen E.;
    • Goland, Robin;
    • Gottlieb, Peter A.;
    • Herold, Kevan C.;
    • Marks, Jennifer B.;
    • Moran, Antoinette;
    • Rodriguez, Henry;
    • Russell, William;
    • Wilson, Darrell M.;
    • Greenbaum, Carla J.
    Publication type:
    journal article
    21

    Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787.

    Published in:
    2018
    By:
    • Sosenko, Jay M;
    • Skyler, Jay S;
    • Mahon, Jeffrey;
    • Krischer, Jeffrey P;
    • Beam, Craig A;
    • Boulware, David C;
    • Greenbaum, Carla J;
    • Rafkin, Lisa E;
    • Cowie, Catherine;
    • Cuthbertson, David;
    • Palmer, Jerry P;
    • and the Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups;
    • Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
    Publication type:
    Correction Notice
    22
    23

    Dysglycemia and Index60 as Prediagnostic End Points for Type 1 Diabetes Prevention Trials.

    Published in:
    2017
    By:
    • Nathan, Brandon M.;
    • Boulware, David;
    • Geyer, Susan;
    • Atkinson, Mark A.;
    • Colman, Peter;
    • Goland, Robin;
    • Russell, William;
    • Wentworth, John M.;
    • Wilson, Darrell M.;
    • Evans-Molina, Carmella;
    • Wherrett, Diane;
    • Skyler, Jay S.;
    • Moran, Antoinette;
    • Sosenko, Jay M.;
    • Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups
    Publication type:
    journal article
    24
    25
    26
    27
    28
    29

    Type 1 Diabetes at a Crossroads!

    Published in:
    Diabetes Care, 2015, v. 38, n. 6, p. 968, doi. 10.2337/dc15-0615
    By:
    • Cefalu, William T.;
    • Tamborlane, William V.;
    • Skyler, Jay S.
    Publication type:
    Article
    30
    31
    32
    33
    34

    Costimulation Modulation With Abatacept in Patients With Recent-Onset Type 1 Diabetes: Follow-up 1 Year After Cessation of Treatment.

    Published in:
    Diabetes Care, 2014, v. 37, n. 4, p. 1069, doi. 10.2337/dc13-0604
    By:
    • Orban, Tihamer;
    • Bundy, Brian;
    • Becker, Dorothy J.;
    • DiMeglio, Linda A.;
    • Gitelman, Stephen E.;
    • Goland, Robin;
    • Gottlieb, Peter A.;
    • Greenbaum, Carla J.;
    • Marks, Jennifer B.;
    • Monzavi, Roshanak;
    • Moran, Antoinette;
    • Peakman, Mark;
    • Raskin, Philip;
    • Russell, William E.;
    • Schatz, Desmond;
    • Wherrett, Diane K.;
    • Wilson, Darrell M.;
    • Krischer, Jeffrey P.;
    • Skyler, Jay S.
    Publication type:
    Article
    35
    36
    37
    38

    Diabetes trends in the USA.

    Published in:
    Diabetes/Metabolism Research & Reviews, 2002, v. 18, p. S21, doi. 10.1002/dmrr.289
    By:
    • Skyler, Jay S.;
    • Oddo, Carolyn
    Publication type:
    Article
    39

    Inhaled human insulin treatment in patients with type 2 diabetes mellitus.

    Published in:
    2001
    By:
    • Cefalu, William T.;
    • Skyler, Jay S.;
    • Kourides, Ione A.;
    • Landschulz, William H.;
    • Balagtas, Cecile C.;
    • Shu-Lin Cheng;
    • Gelfand, Robert A.;
    • Cefalu, W T;
    • Skyler, J S;
    • Kourides, I A;
    • Landschulz, W H;
    • Balagtas, C C;
    • Cheng, S;
    • Gelfand, R A;
    • Inhaled Insulin Study Group
    Publication type:
    journal article
    40
    41
    42

    Insulin Action During Pregnancy.

    Published in:
    Diabetes, 1985, v. 34, n. 4, p. 380, doi. 10.2337/diab.34.4.380
    By:
    • Ryan, Edmond A.;
    • O'Suliivan, Mary Jo;
    • Skyler, Jay S.
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50